Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients.
Min-Kyoung KimKyung-Shin LeeSin Young HamYoun Young ChoiEunyoung LeeSeungjae LeeBora LeeJae-Hyun JeonBum Sik ChinYeonjae KimGayeon KimHee-Chang JangJae Phil ChoiWan Beom ParkPublished in: Journal of Korean medical science (2023)
Nirmatrelvir-ritonavir treatment significantly reduced oxygen therapy requirements in high-risk patients with COVID-19 during the omicron variant surge in South Korea. Physicians are encouraged to consider the active use of nirmatrelvir-ritonavir and to be watchful for gastrointestinal symptoms during medication.